Cumberland Pharmaceuticals
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Purchase
JONES JAMES director
Common Stock 21 $4.14 $87
Purchase
KROGULSKI KENNETH director
Common Stock 75 $4.14 $311
Purchase
YOUNG CAROLINE director
Common Stock 18 $4.14 $75
Purchase
KAZIMI A J director, 10 percent owner, off..
Common Stock 35 $4.61 $161
Purchase
YOUNG CAROLINE director
Common Stock 35 $4.61 $161
Purchase
JONES JAMES director
Common Stock 42 $4.61 $194
Purchase
CEARNAL MARTIN E director, officer: Sr VP/Chief ..
Common Stock 175 $4.61 $807
Purchase
KROGULSKI KENNETH director
Common Stock 150 $4.61 $692
Purchase
CEARNAL MARTIN E director, officer: Sr VP/Chief ..
Common Stock 175 $2.23 $390
Purchase
YOUNG CAROLINE director
Common Stock 35 $2.23 $78
Purchase
KROGULSKI KENNETH director
Common Stock 150 $2.23 $335
Purchase
KAZIMI A J director, 10 percent owner, off..
Common Stock 35 $2.23 $78
Purchase
JONES JAMES director
Common Stock 42 $2.23 $94
Purchase
KAZIMI A J director, 10 percent owner, off..
Common Stock 35 $2.26 $79
Purchase
KROGULSKI KENNETH director
Common Stock 150 $2.26 $339
Purchase
YOUNG CAROLINE director
Common Stock 35 $2.26 $79
Purchase
JONES JAMES director
Common Stock 42 $2.26 $95
Purchase
CEARNAL MARTIN E director, officer: Sr VP/Chief ..
Common Stock 175 $2.26 $395
Purchase
CEARNAL MARTIN E director, officer: Sr VP/Chief ..
Common Stock 175 $2.31 $404
Purchase
JONES JAMES director
Common Stock 42 $2.31 $97
Purchase
KAZIMI A J director, 10 percent owner, off..
Common Stock 35 $2.31 $81
Purchase
KROGULSKI KENNETH director
Common Stock 150 $2.31 $347
Purchase
YOUNG CAROLINE director
Common Stock 35 $2.31 $81
Purchase
YOUNG CAROLINE director
Common Stock 15 $2.29 $34
Purchase
JONES JAMES director
Common Stock 42 $2.29 $96
Purchase
CEARNAL MARTIN E director, officer: Sr VP/Chief ..
Common Stock 105 $2.29 $240
Purchase
KROGULSKI KENNETH director
Common Stock 85 $2.29 $195
Purchase
HAMM JOHN M. officer: Chief Financial Officer
Common Stock 3,800 $2.35 $8,930
Purchase
KAZIMI A J director, 10 percent owner, off..
Common Stock 15 $2.29 $34
Purchase
CEARNAL MARTIN E director, officer: Sr VP/Chief ..
Common Stock 105 $2.35 $247
Purchase
KAZIMI A J director, 10 percent owner, off..
Common Stock 15 $2.35 $35
Purchase
JONES JAMES director
Common Stock 42 $2.35 $99
Purchase
KROGULSKI KENNETH director
Common Stock 85 $2.35 $200
Purchase
YOUNG CAROLINE director
Common Stock 15 $2.35 $35
Purchase
GALANTE JOSEPH C director
Common Stock 75 $3.08 $231
Purchase
GALANTE JOSEPH C director
Common Stock 142 $3.31 $470
Purchase
CEARNAL MARTIN E director, officer: Sr VP/Chief ..
Common Stock 105 $3.31 $348
Purchase
JONES JAMES director
Common Stock 42 $3.31 $139
Purchase
KROGULSKI KENNETH director
Common Stock 85 $3.31 $281
Purchase
CEARNAL MARTIN E director, officer: Sr VP/Chief ..
Common Stock 105 $3.31 $348
Purchase
KROGULSKI KENNETH director
Common Stock 85 $3.31 $281
Purchase
GALANTE JOSEPH C director
Common Stock 142 $3.31 $470
Purchase
JONES JAMES director
Common Stock 42 $3.31 $139
Purchase
KROGULSKI KENNETH director
Common Stock 85 $3.31 $281
Purchase
GALANTE JOSEPH C director
Common Stock 142 $3.31 $470
Purchase
JONES JAMES director
Common Stock 42 $3.31 $139
Purchase
CEARNAL MARTIN E director, officer: Sr VP/Chief ..
Common Stock 105 $3.31 $348
Purchase
JONES JAMES director
Common Stock 42 $3.31 $139
Purchase
GALANTE JOSEPH C director
Common Stock 142 $3.31 $470
Purchase
CEARNAL MARTIN E director, officer: Sr VP/Chief ..
Common Stock 105 $3.31 $348

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.